Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
80 Results for "
α-synuclein aggregation
" in MedChemExpress (MCE) Product Catalog:
Products (80)
80 Results for "α-synuclein aggregation" in MCE Product Catalog:
Cat. No.: HY-152552
CAS No.: 2883627-64-1
Target:
Research Areas:
α-Synuclein inhibitor 8 is an active inhibitor of α-Synuclein with an IC50 value of 2.5 µM. α-Synuclein inhibitor 8 has highly inhibition on the aggregation and disaggregation of α-Synuclein fibers. α-Synuclein inhibitor 8 reduces the formation of inclusions in neurons that can repairs damage neurons and improves Parkinson’s disease (PD)-like symptoms. α-Synuclein inhibitor 8 has high antioxidant activity and low cytotoxicity .
Category:
Umbelliferae Extract Rudbeckia laciniata L. Ketones, Aldehydes, Acids Plants Endogenous metabolite
Target:
Cat. No.: HY-149509
CAS No.: 1510825-03-2
Target:
Research Areas:
α-Synuclein inhibitor 9 (Compound 20C) is an α-Synuclein inhibitor. α-Synuclein inhibitor 9 binds to cavities in mature α-synuclein fibrils and reduces the β-sheet structure. α-Synuclein inhibitor 9 inhibits A53T α-Syn aggregation. α-Synuclein inhibitor 9 has neuroprotective effect, improves brain functional connection and relieves motor dysfunction.α-Synuclein inhibitor 9 can be used for Parkinson’s disease (PD) research. .
Cat. No.: HY-163519
Target:
Research Areas:
α-Synuclein inhibitor 13 is an inhibitor of α-synuclein (α-Syn). α-Synuclein inhibitor 13 inhibits the aggregation of α-Syn proteins and is able to break down formed fibers. It is mainly used in Parkinson's disease research .
Cat. No.: HY-157806
Target:
Research Areas:
α-Synuclein inhibitor 12 (compound 4ce) is an inhibitor of α-Syn (α-synuclein) aggregation and can be used in the study of neurological diseases .
Research Areas:
Sulfamerazine (Standard) is the analytical standard of Sulfamerazine. This product is intended for research and analytical applications. Sulfamerazine (RP2632) is a brain-penetrant and orally active sulfonamide antibiotic and α-synuclein inhibitor with human α-synuclein KD of 352 μM. Sulfamerazine inhibits the synthesis of dihydrofolate by bacteria, thereby inhibiting bacterial growth. Sulfamerazine inhibits α-synuclein fibrillation, reduces α-synuclein aggregation-associated toxicity and α-synuclein aggregate accumulation. Sulfamerazine can be used for the research of Parkinson’s disease and bacterial infection .
Cat. No.: HY-B0512S
CAS No.: 1020719-84-9
Synonyms: RP2632-d4
Cat. No.: HY-144696
CAS No.: 2789711-66-4
Target:
Research Areas:
Dyrk1A/α-synuclein-IN-2 (Compound b20) is a dual Dyrk1A and α-synuclein aggregation inhibitor with an IC50 of 7.8 µM for α-synuclein. Dyrk1A/α-synuclein-IN-2 has high predictive CNS penetration and neuroprotective effect .
Cat. No.: HY-B0512S1
CAS No.: 1196157-80-8
Synonyms: RP2632-13C6
Cat. No.: HY-147666
CAS No.: 2489813-08-1
Target:
Research Areas:
α-Synuclein inhibitor 4 (compound 3gh) is a potent and BBB-penetrated inhibitor of α-Synuclein (α-Syn) aggregation, with an IC50 of 0.98 μM and inhibition ratio at 30 μM of 91.2% .
Cat. No.: HY-147667
CAS No.: 2489813-11-6
Target:
Research Areas:
α-Synuclein inhibitor 5 (compound 4aa) is a potent and BBB-penetrated inhibitor of α-Synuclein (α-Syn) aggregation, with an IC50 of 1.22 μM and inhibition ratio at 30 μM of 94.3% .
Cat. No.: HY-147668
CAS No.: 2489813-02-5
Target:
Research Areas:
α-Synuclein inhibitor 6 (compound 3ge) is a potent and BBB-penetrated inhibitor of α-Synuclein (α-Syn) aggregation, with an IC50 of 1.70 μM and inhibition ratio at 30 μM of 94.4% .
Cat. No.: HY-147669
CAS No.: 2489813-04-7
Target:
Research Areas:
α-Synuclein inhibitor 7 (compound 3gf) is a potent and BBB-penetrated inhibitor of α-Synuclein (α-Syn) aggregation, with an IC50 of 1.95 μM and inhibition ratio at 30 μM of 85.8% .
Cat. No.: HY-130398
CAS No.: 87075-23-8
Category:
Target:
Cat. No.: HY-N0698R
CAS No.: 55750-84-0
Cat. No.: HY-163613
CAS No.: 3069546-41-1
Target:
Research Areas:
NS163 is a α-Synuclein aggregation antagonist. NS163 can be used for study of Parkinson’s disease .
Cat. No.: HY-N0901AR
CAS No.: 17391-18-3
Category:
Uncaria rhynchophylla (Miq.) Miq. ex Havil. Alkaloids Plants Indole Alkaloids Rubiaceae Extract
Target:
Cat. No.: HY-144695
CAS No.: 2789711-47-1
Target:
Research Areas:
Dyrk1A/α-synuclein-IN-1 (Compound b1) is a dual Dyrk1A and α-synuclein aggregation inhibitor with IC50 values of 177 nM and 10.5 µM, respectively. Dyrk1A/α-synuclein-IN-1 has high predictive CNS penetration and neuroprotective effect .
Cat. No.: HY-P10404
CAS No.: 2942277-55-4
Target:
Research Areas:
Cat. No.: HY-163739
CAS No.: 951131-13-8
Target:
Research Areas:
LETC is an orally active α-synuclein (α-Syn) aggregation inhibitor with an EC50 of 66 nM in transfected DH60.21 neuroblastoma cells. LETC can cross the blood-brain barrier. LETC can be used for the study of synucleinopathies .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
